|
|
|
|
|
by gdudeman
20 days ago
|
|
This really isn't the case in the Shingles vaccine unless the UK study is flawed a way that isn't clear to me. The study looked at the effect of being eligible for a vaccine and the results were clear. (see chart below the fold here: https://erictopol.substack.com/p/the-shingles-vaccine-and-re...) There was a hard age cutoff in the UK study. Above a certain age, you weren't eligible. Below it, you were. People who were born in the "can get the vaccine" group have markedly lower rates of dementia. People in the "too old" group have higher rates. It's one of those studies where you don't even need to look at the p-value to see the difference. I'm very open to being wrong about this! |
|
But in your summary:
> People who were born in the "can get the vaccine" group have markedly lower rates of dementia. People in the "too old" group have higher rates.
I would change "people" to "women". I thought it was very interesting that the benefit of the Shingles vaccine eligibility for Alzheimer's was largely confined to women - men showed no such benefit per the graph in that substack article.